NCT04963465

Brief Summary

Although much investigation has been done on the use of ferning in the second and third trimesters, particularly with the development of rapid protein clinical assays, there appears to be lower ferning rates in clinical practice with traditional techniques compared to previous published research on the subject. Much of the older study designs are lacking in detail and lack a large enough sample sizes at each gestational age to appropriately interpret the significance of ferning results by gestational age. Additionally, a large premise for the current tests used to diagnose rupture of membranes is based on these older studies. Given this, we propose collecting amniotic fluid vaginally to evaluate for the presence of ferning in the second trimester to determine if there is a difference in ferning based on gestational age as well as the time interval after rupture of membranes in which ferning can observed on microscope examination.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

September 17, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

2.2 years

First QC Date

July 6, 2021

Last Update Submit

April 14, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Ferning

    the presence of amniotic fluid ferning

    1 minute

  • Ferning

    the presence of amniotic fluid ferning

    5 minutes

  • Ferning

    the presence of amniotic fluid ferning

    10 minutes

  • Ferning

    the presence of amniotic fluid ferning

    15 minutes

  • Ferning

    the presence of amniotic fluid ferning

    20 minutes

Study Arms (2)

Before rupture of membranes

Vaginal swab collection prior to iatrogenic rupture of membranes

Diagnostic Test: Ferning on microscopy

After rupture of membranes

Vaginal swab collection after iatrogenic rupture of membranes

Diagnostic Test: Ferning on microscopy

Interventions

Ferning on microscopyDIAGNOSTIC_TEST

Amniotic fluid ferning will be assessed in the cohort before known rupture of membranes and after known rupture of membranes

After rupture of membranesBefore rupture of membranes

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Prospective observational study including pregnant women 18 years or older who present for pregnancy termination, between 15 and 24 weeks gestation. Women with a singleton or multi-fetal gestation, who have previously established dating based on a first trimester ultrasound or ultrasound prior to 22 weeks gestation, will be included. Exclusion criterion are women who are less than 18 years of age, non-English speaking, and rupture of membranes or anhydramnios (no measurable amniotic fluid on ultrasound) at the time of data collection in the operating room.

You may qualify if:

  • years or older
  • English speaking
  • singleton or multi fetal gestation
  • between 15 and 24 weeks gestation
  • undergoing elective pregnancy termination

You may not qualify if:

  • known rupture of membranes or anhydramnios

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albany Medical Center

Albany, New York, 12208, United States

RECRUITING

MeSH Terms

Conditions

Preterm Premature Rupture of the Membranes

Study Officials

  • OBGYN Research Director

    Albany Medical College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

OBGYN Research Director

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2021

First Posted

July 15, 2021

Study Start

September 17, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

April 18, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations